Lv4
740 积分 2025-03-06 加入
The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond
1天前
已完结
Mechanisms of resistance to antibody–drug conjugates in cancers
9天前
已完结
Antibody-drug conjugates in oncology: A spotlight on overcoming resistance
23天前
已完结
Contemporary design of small-molecule kinase modulators: orthosteric, allosteric and induced-proximity strategies
28天前
已完结
Dual-payload antibody–drug conjugates: Taking a dual shot
1个月前
已完结
Unlocking biological barriers: nonclinical safety considerations for RNA-based complex biologics
1个月前
已完结
P30-23 Boosting Early-Stage ADC Toxicity assessment through human in vitro cell models
2个月前
已关闭
Mapping covalent drug targets
2个月前
已完结
Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications
3个月前
已完结
Strategies for blood–brain barrier rejuvenation and repair
3个月前
已完结
皖公网安备34019202002308
